Literature DB >> 17196962

EGF AND TGF-alpha motogenic activities are mediated by the EGF receptor via distinct matrix-dependent mechanisms.

Ian R Ellis1, Ana M Schor, Seth L Schor.   

Abstract

EGF and TGF-alpha induce an equipotent stimulation of fibroblast migration and proliferation. In spite of their homologous structure and ligation by the same receptor (EGFR), we report that their respective motogenic activities are mediated by different signal transduction intermediates, with p70(S6K) participating in EGF signalling and phospholipase Cgamma in TGF-alpha signalling. We additionally demonstrate that EGF and TGF-alpha motogenic activities may be resolved into two stages: (a) cell "activation" by a transient exposure to either cytokine, and (b) the subsequent "manifestation" of an enhanced migratory phenotype in the absence of cytokine. The cell activation and manifestation stages for each cytokine are mediated by distinct matrix-dependent mechanisms: motogenetic activation by EGF requires the concomitant functionality of EGFR and the hyaluronan receptor CD44, whereas activation by TGF-alpha requires EGFR and integrin alphavbeta3. Manifestation of elevated migration no longer requires the continued presence of exogenous cytokine and functional EGFR but does require the above mentioned matrix receptors, as well as their respective ligands, i.e., hyaluronan in the case of EGF, and vitronectin in the case of TGF-alpha. In contrast, the mitogenic activities of EGF and TGF-alpha are independent of CD44 and alphavbeta3 functionality. These results demonstrate clear qualitative differences between EGF and TGF-alpha pathways and highlight the importance of the extracellular matrix in regulating cytokine bioactivity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17196962     DOI: 10.1016/j.yexcr.2006.11.016

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  14 in total

Review 1.  Regenerative potential of glycosaminoglycans for skin and bone.

Authors:  Juliane Salbach; Tilman D Rachner; Martina Rauner; Ute Hempel; Ulf Anderegg; Sandra Franz; Jan-Christoph Simon; Lorenz C Hofbauer
Journal:  J Mol Med (Berl)       Date:  2011-12-21       Impact factor: 4.599

2.  Differential recruitment of CD44 isoforms by ErbB ligands reveals an involvement of CD44 in breast cancer.

Authors:  Iris Morath; Christian Jung; Romain Lévêque; Chen Linfeng; Robert-Alain Toillon; Arne Warth; Véronique Orian-Rousseau
Journal:  Oncogene       Date:  2018-01-11       Impact factor: 9.867

3.  Hyaluronan facilitates transforming growth factor-β1-dependent proliferation via CD44 and epidermal growth factor receptor interaction.

Authors:  Soma Meran; Dong Dong Luo; Russell Simpson; John Martin; Alan Wells; Robert Steadman; Aled O Phillips
Journal:  J Biol Chem       Date:  2011-03-25       Impact factor: 5.157

4.  Transforming growth factor-β1 (TGF-β1)-stimulated fibroblast to myofibroblast differentiation is mediated by hyaluronan (HA)-facilitated epidermal growth factor receptor (EGFR) and CD44 co-localization in lipid rafts.

Authors:  Adam C Midgley; Mathew Rogers; Maurice B Hallett; Aled Clayton; Timothy Bowen; Aled O Phillips; Robert Steadman
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

5.  Aging fibroblasts resist phenotypic maturation because of impaired hyaluronan-dependent CD44/epidermal growth factor receptor signaling.

Authors:  Russell M L Simpson; Alan Wells; David Thomas; Philip Stephens; Robert Steadman; Aled Phillips
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

6.  Different epidermal growth factor (EGF) receptor ligands show distinct kinetics and biased or partial agonism for homodimer and heterodimer formation.

Authors:  Jennifer L Macdonald-Obermann; Linda J Pike
Journal:  J Biol Chem       Date:  2014-08-01       Impact factor: 5.157

7.  Autocrine-derived epidermal growth factor receptor ligands contribute to recruitment of tumor-associated macrophage and growth of basal breast cancer cells in vivo.

Authors:  Nicole K Nickerson; Christopher P Mill; Hsin-Jung Wu; David J Riese; John Foley
Journal:  Oncol Res       Date:  2013       Impact factor: 5.574

8.  Wounding-induced synthesis of hyaluronic acid in organotypic epidermal cultures requires the release of heparin-binding egf and activation of the EGFR.

Authors:  James Monslow; Nobuyuki Sato; Judith A Mack; Edward V Maytin
Journal:  J Invest Dermatol       Date:  2009-02-19       Impact factor: 8.551

Review 9.  Functional selectivity of EGF family peptide growth factors: implications for cancer.

Authors:  Kristy J Wilson; Jennifer L Gilmore; John Foley; Mark A Lemmon; David J Riese
Journal:  Pharmacol Ther       Date:  2008-12-16       Impact factor: 12.310

10.  A novel fragment derived from the beta chain of human fibrinogen, beta43-63, is a potent inhibitor of activated endothelial cells in vitro and in vivo.

Authors:  E Krajewska; C E Lewis; Y-Y Chen; A Welford; S Tazzyman; C A Staton
Journal:  Br J Cancer       Date:  2010-01-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.